Literature DB >> 17538153

Complete, long-standing regression of hepatocellular carcinoma after somatostatin analogue treatment.

Gabriel Rahmi, David Malka, Gorana Tomasic, Clarisse Dromain, Michel Ducreux, Valérie Boige.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17538153     DOI: 10.1200/JCO.2006.09.5760

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma.

Authors:  Lynn G Feun; Medhi Wangpaichitr; Ying-Ying Li; Deukwoo Kwon; Stephen P Richman; Peter J Hosein; Niramol Savaraj
Journal:  J Hepatocell Carcinoma       Date:  2018-01-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.